Specifically, we distinguish the tumor-specific immune abilities of CD8+ and CD4+ T cells: effector CD8+ T cells directly kill susceptible and infected tumor cells while CD4+ T cells kill tumor cells indirectly through cytokines. This evidence concerns the gene CD4 and neoplasm.